BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24684737)

  • 21. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities.
    Ichiyama S; Ito M; Funasaka Y; Abe M; Nishida E; Muramatsu S; Nishihara H; Kato H; Morita A; Imafuku S; Saeki H
    J Dermatol; 2018 Jun; 45(6):727-731. PubMed ID: 29356075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical psoriasis therapy.
    Federman DG; Froelich CW; Kirsner RS
    Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical therapy for psoriasis.
    Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
    Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
    [No Abstract]   [Full Text] [Related]  

  • 24. Comment on topical lomustine therapy for psoriasis.
    Kligman AM
    Arch Dermatol; 1973 Aug; 108(2):273-4. PubMed ID: 4269285
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcipotriene for psoriasis.
    Med Lett Drugs Ther; 1994 Aug; 36(928):70-1. PubMed ID: 8035754
    [No Abstract]   [Full Text] [Related]  

  • 26. Adherence to treatment: still the forgotten variable.
    Rajpara AN; Feldman SR
    Arch Dermatol; 2010 Oct; 146(10):1183-4; author reply 1184. PubMed ID: 20956666
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
    Scheinfeld NS
    Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
    [No Abstract]   [Full Text] [Related]  

  • 28. Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?
    Giomi B; Ruggiero M; Fabbri P; Gulisano M; Peruzzi B; Caproni M; Pacini S
    J Dermatol Sci; 2005 Mar; 37(3):180-1. PubMed ID: 15734288
    [No Abstract]   [Full Text] [Related]  

  • 29. Topical therapies for the treatment of plaque psoriasis.
    Bagel J
    Cutis; 2009 Oct; 84(4 Suppl):3-13. PubMed ID: 19916297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [When creams turn into a burden].
    Failla V; Wauters O; Raty L; Caucanas M; Richert B; Dezfoulian B; Nikkels AF
    Rev Med Liege; 2010; 65(5-6):423-5. PubMed ID: 20684432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys.
    Vender R; Gooderham MJ; Guenther LC; Kyritsis D; Rao J; Kowalczyk A; Ashkenas J
    J Cutan Med Surg; 2018; 22(5):464-471. PubMed ID: 29754528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New topical psoriasis treatment.
    Holdcroft C
    Nurse Pract; 1995 Mar; 20(3):15-6. PubMed ID: 7761036
    [No Abstract]   [Full Text] [Related]  

  • 34. The topical treatment of psoriasis.
    van de Kerkhof PC
    Clin Exp Dermatol; 2005 Mar; 30(2):205-8. PubMed ID: 15725262
    [No Abstract]   [Full Text] [Related]  

  • 35. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
    Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
    Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R
    Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356
    [No Abstract]   [Full Text] [Related]  

  • 37. The management of psoriasis-tazarotene: the bottom line.
    Weinstein GD
    Cutis; 1998 Feb; 61(2 Suppl):38-9. PubMed ID: 9787992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alefacept treatment for chronic plaque psoriasis.
    Dunn LK; Feldman SR
    Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective assessment of compliance with psoriasis treatment.
    Zaghloul SS; Goodfield MJ
    Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme.
    de Korte J; Van Onselen J; Kownacki S; Sprangers MA; Bos JD
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):35-41. PubMed ID: 15649189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.